Practical spectrophotometric assay for the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase, a potential antibiotic target
- PMID: 29698518
- PMCID: PMC5919655
- DOI: 10.1371/journal.pone.0196010
Practical spectrophotometric assay for the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase, a potential antibiotic target
Abstract
A new enzymatic assay for the bacterial enzyme succinyl-diaminopimelate desuccinylase (DapE, E.C. 3.5.1.18) is described. This assay employs N6-methyl-N2-succinyl-L,L-diaminopimelic acid (N6-methyl-L,L-SDAP) as the substrate with ninhydrin used to detect cleavage of the amide bond of the modified substrate, wherein N6-methylation enables selective detection of the primary amine enzymatic product. Molecular modeling supported preparation of the mono-N6-methylated-L,L-SDAP as an alternate substrate for the assay, given binding in the active site of DapE predicted to be comparable to the endogenous substrate. The alternate substrate for the assay, N6-methyl-L,L-SDAP, was synthesized from the tert-butyl ester of Boc-L-glutamic acid employing a Horner-Wadsworth-Emmons olefination followed by an enantioselective reduction employing Rh(I)(COD)(S,S)-Et-DuPHOS as the chiral catalyst. Validation of the new ninhydrin assay was demonstrated with known inhibitors of DapE from Haemophilus influenza (HiDapE) including captopril (IC50 = 3.4 [± 0.2] μM, 3-mercaptobenzoic acid (IC50 = 21.8 [±2.2] μM, phenylboronic acid (IC50 = 316 [± 23.6] μM, and 2-thiopheneboronic acid (IC50 = 111 [± 16] μM. Based on these data, this assay is simple and robust, and should be amenable to high-throughput screening, which is an important step forward as it opens the door to medicinal chemistry efforts toward the discovery of DapE inhibitors that can function as a new class of antibiotics.
Conflict of interest statement
Figures






Similar articles
-
Substrate specificity, metal binding properties, and spectroscopic characterization of the DapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Haemophilus influenzae.Biochemistry. 2003 Sep 16;42(36):10756-63. doi: 10.1021/bi034845+. Biochemistry. 2003. PMID: 12962500
-
Synthesis and characterization of the N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) alternate substrate analog N,N-dimethyl-l,l-SDAP.Bioorg Med Chem. 2023 Aug 15;91:117415. doi: 10.1016/j.bmc.2023.117415. Epub 2023 Jul 12. Bioorg Med Chem. 2023. PMID: 37459673
-
The dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Haemophilus influenzae contains two active-site histidine residues.J Biol Inorg Chem. 2009 Jan;14(1):1-10. doi: 10.1007/s00775-008-0418-z. Epub 2008 Aug 19. J Biol Inorg Chem. 2009. PMID: 18712420 Free PMC article.
-
Lysine biosynthesis in bacteria: a metallodesuccinylase as a potential antimicrobial target.J Biol Inorg Chem. 2013 Feb;18(2):155-163. doi: 10.1007/s00775-012-0965-1. Epub 2012 Dec 8. J Biol Inorg Chem. 2013. PMID: 23223968 Free PMC article. Review.
-
Enzymology of bacterial lysine biosynthesis.Adv Enzymol Relat Areas Mol Biol. 1998;72:279-324. doi: 10.1002/9780470123188.ch8. Adv Enzymol Relat Areas Mol Biol. 1998. PMID: 9559056 Review.
Cited by
-
Indoline-6-Sulfonamide Inhibitors of the Bacterial Enzyme DapE.Antibiotics (Basel). 2020 Sep 11;9(9):595. doi: 10.3390/antibiotics9090595. Antibiotics (Basel). 2020. PMID: 32933028 Free PMC article.
-
Cyclobutanone Inhibitors of Diaminopimelate Desuccinylase (DapE) as Potential New Antibiotics.Int J Mol Sci. 2024 Jan 22;25(2):1339. doi: 10.3390/ijms25021339. Int J Mol Sci. 2024. PMID: 38279338 Free PMC article.
-
Transporters and Efflux Pumps Are the Main Mechanisms Involved in Staphylococcus epidermidis Adaptation and Tolerance to Didecyldimethylammonium Chloride.Microorganisms. 2020 Feb 29;8(3):344. doi: 10.3390/microorganisms8030344. Microorganisms. 2020. PMID: 32121333 Free PMC article.
-
The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics.RSC Med Chem. 2024 Apr 19;15(6):2018-2029. doi: 10.1039/d4md00073k. eCollection 2024 Jun 19. RSC Med Chem. 2024. PMID: 38911160 Free PMC article.
-
N α -acetyl-L-ornithine deacetylase from Escherichia coli and a ninhydrin-based assay to enable inhibitor identification.Front Chem. 2024 Jul 11;12:1415644. doi: 10.3389/fchem.2024.1415644. eCollection 2024. Front Chem. 2024. PMID: 39055043 Free PMC article.
References
-
- World Health Organization. Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis. 2017. http://www.who.int/medicines/areas/rational_use/antibacterial_agents_cli...
-
- Klevens RM, Morrison MA, Nadle J, Petit S, Gershrnan K, Ray S, et al. Invasive methicillin-resistant staphylococcus aureus infections in the United States. JAMA, J Am Med Assoc. 2007; 298: 1763–1771. - PubMed
-
- Howe RA, Bowker KE, Walsh TR, Feest TG, MacGowan AP. Vancomycin-resistant Staphylococcus aureus. Lancet. 1998; 351: 602 doi: 10.1016/S0140-6736(05)78597-4 - DOI - PubMed
-
- Gillner DM, Becker DP, Holz RC. Lysine biosynthesis in bacteria: a metallodesuccinylase as a potential antimicrobial target. JBIC, J Biol Inorg Chem. 2013; 18: 155–163. doi: 10.1007/s00775-012-0965-1 - DOI - PMC - PubMed
-
- Scapin G, Blanchard JS. Enzymology of bacterial lysine biosynthesis. Adv Enzymol Relat Areas Mol Biol. 1998; 72: 279–324. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical